Business Standard

Sun Pharma Q4 net more than doubles to Rs 894 cr; declares dividend of Rs 2

Its revenue from operations came in at Rs 8,522 crore for the quarter under review, an increase of 4 per cent from the previous year

Sun Pharma
Premium

BS Web Team New Delhi
Sun Pharma on Thursday reported 123 per cent year-on-year increase in consolidated net profit at Rs 894 crore for the quarter ending March 31, 2021. It was Rs 399.8 crore in the year-ago period.

However, the profit was still below the Street's expectation of over Rs 1,200 crore on account of exceptional loss worth Rs 672.8 crore related to various litigation settlements pertaining to some of its subsidiaries.

Sun Pharma said the adjusted net profit came in at Rs 1,343 crore, up 103 per cent year-on-year. 

Its revenue from operations came in at Rs 8,522 crore for the quarter under

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in